SUNRISE, FL / ACCESSWIRE / November 12, 2014 / Bioheart, Inc. , a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced today that the first successful intracoronary implantation of autologous adipose-derived stem cell was performed to a 70 year-old male patient with ischemic cardiomyopathy by Emrah Anar MD in Baku Cardiac Center of Central Military Hospital. "Bioheart is bringing regenerative therapies to patients around the world," said Kristin Comella, Chief Science officer of Bioheart.
http://ift.tt/1sE0OWY
http://ift.tt/1sE0OWY
No comments:
Post a Comment